Prostate Specific Antigen

Prostate cancer is one of the most common cancers diagnosed in Australia. It is estimated that just over 16,000 new cases will be diagnosed this year (23 % of all new cancers).

Even though the five-year survival rate is > 95%, prostate cancer mortality (12.7 % of all cancer deaths) is expected to be the third highest after lung and colorectal cancer this year. (Prostate cancer statistics | Prostate Cancer, 2017)

Serum prostate-specific antigen (PSA) is an effective marker of prostate cancer; its value as a screening tool is less certain. (Prcic, Begic, and Hiros, 2016)

 ...

This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.

Existing Users Log In